跳至主要内容
临床试验/IRCT201410265968N5
IRCT201410265968N5招募中2 期

Assessment of rosehip supplement consumption on fatty liver grade and liver enzymes in comparison with control group in patients with fatty liver

Brain and Spinal injury Research Centre0 个研究点目标入组 78 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 69 years(—)
性别
All

入选标准

  • 1.Age between 18 and 70 years 2.Fatty liver disease. Exclusion criteria: 1. Alcohol consumption 2.Smoking 3.taking certain medication, such as blood pressure medications, Insulin sensitivity enhancers, statins, hepatotoxic drugs such as Phenytoin, tamoxifen, lithium and supplements 4. Acute liver disorders such as Hepatitis B and C, liver transplantation, biliary disease known as autoimmune disease, cancer, inherited disorders affecting liver condition (iron and copper storage disease) and other disease 5.Failure to sign the ethical consent.

排除标准

  • 未提供

研究者

发起方
Brain and Spinal injury Research Centre

相似试验